Xeris Biopharma Holdings Inc (FRA:2B30)
€ 7.11 +0.020 (+0.28%) Market Cap: 1.27 Bil Enterprise Value: 1.40 Bil PE Ratio: 139.67 PB Ratio: 111.73 GF Score: 74/100

Xeris Biopharma Holdings Inc (FRA:2B30) Transcripts

  • 1